Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 0.44 |
| ▸ | BCHE | P06276 | 9/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | NOX1 | Q9Y5S8 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30851251 | 0.82 | NOX1 (0.54) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL1926804 | 0.82 | NOX1 (0.54) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL244957 | 0.80 | MAPK1 (0.64) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL18408661 | 0.78 | MAPK1 (0.55) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL396463 | 0.78 | BCHE (0.61) | SNCABCHEKMT2AACHENOX1 | |
| SCHEMBL12955933 | 0.76 | MEN1 (0.63) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL8223437 | 0.75 | NOX1 (0.46) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL22726491 | 0.75 | MAPK1 (0.54) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL15963115 | 0.74 | MEN1 (0.81) | SNCABCHEMEN1MAPK1KMT2A | |
| SCHEMBL14142982 | 0.72 | BCHE (0.61) | SNCABCHEACHENOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12264356-B2 | Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor | NIHON UNIVERSITY (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20200347458-A1 | METHOD FOR DETERMINING SENSITIVITY TO SGLT2 INHIBITOR AND SENSITIVITY MARKER FOR SGLT2 INHIBITOR | NIHON UNIVERSITY (JP) | 2020-11-05 | — | — | US | disclosed |
| CN-111575339-A | 1, 5-anhydroglucitol enzymatic quantitative method and reagent therefor | 王学忠 | 2020-08-25 | — | — | CN | disclosed |
| EP-2319937-B1 | BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD | NIPPON KAYAKU KK (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-8883439-B2 | Blood component measurement method utilizing hemolyzed whole blood, and kit for the method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8753832-B2 | Method of assaying 1,5 anhydroglucitol by using whole blood and measurement kit | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20110165608-A1 | BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-07 | — | — | US | disclosed |
| EP-1895303-B1 | METHOD OF ASSAYING 1, 5-ANHYDROGLUCITOL BY USING WHOLE BLOOD | NIPPON KAYAKU KK (JP) | 2011-05-11 | — | — | EP | disclosed |
| EP-2319937-A1 | BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD | Nippon Kayaku Kabushiki Kaisha (JP) | 2011-05-11 | — | — | EP | disclosed |
| US-20100075352-A1 | Method of assaying bolld component by using whole blood and measurement kit | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-03-25 | — | — | US | disclosed |
| EP-1895303-A1 | METHOD OF ASSAYING BLOOD COMPONENT BY USING WHOLE BLOOD AND MEASUREMENT KIT | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-6448029-B1 | USING NUCLEOTIDE DIPHOSPHATE OR TRIPHOSPHATE | KYOWA MEDEX CO., LTD. (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-1213357-A2 | Method and reagent for quantitative determination of 1, 5-Anhydroglucitol | KYOWA MEDEX CO., LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-20020068310-A1 | Method and reagant for quantitative determination of 1,5-anhydroglucitol | KYOWA MEDEX CO., LTD. (JP) | 2002-06-06 | — | — | US | disclosed |
| US-6309852-B1 | CONTACTING THE SAMPLE WITH AN ENZYME SUCH AS NUCLEOSIDE DIPHOSPHATE, TRIPHOSPHATE AND NUCLEOSIDE DEPENDENT ENZYMES SYSTEM WHICH CONVERTS GLUCOSE INTO FRUCTOSE 1,6-DIPHOSPHATE AND 1,5-ANHYDROGLUCITOL (1,5-AG)TO 1,5-AG-6-PHOSPHATE | KYOWA MEDEX CO., LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| CN-1257128-A | Method for quantifying 1,5-anhydrosorbierite and quantitative reagent | KYOWA MEDEX CO LTD (JP) | 2000-06-21 | — | — | CN | disclosed |
| EP-1008657-A2 | Method and reagent for quantitative determination of 1,5-anhydroglucitol | KYOWA MEDEX CO., LTD. (JP) | 2000-06-14 | — | — | EP | disclosed |
| EP-0843019-A2 | Method for determination of specific nucleic acid sequence, and a reagent therefor | KYOWA MEDEX CO., LTD. (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5426033-A | Accurate quantitative analysis | KYOWA MEDEX CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0608795-A1 | Method for enzymatic determination of substrate after enzymatically removing galactose | Kyowa Medex Co. Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |